The Komen promise is to save lives and end breast cancer forever by empowering people, ensuring quality care for all and energizing science to find the cures. The Oregon and SW Washington Affiliate seeks to ensure that all people, regardless of race, income, geographic location, or insurance status have access to screening, quality breast cancer treatment and support services.
Screening & Regional Educational Network (SCREEN) Grants - $60,000 each
The purpose of the Screening & Regional Education Network grants are to provide life-saving educational messages to women throughout the full 39 county service area. The local Affiliate has designated seven regions and five target populations that it will serve with grants up to $60,000 each year for a period of five years. The Affiliate has prioritized the regions and target groups to be implemented over the next few years, as funding is available. Currently, SCREEN programs are operating in the Mid-Willamette region and in the Souther Oregon Region. The next region to implement the Screening and Education initiative will be the Eastern Oregon Region serving Wallowa, Union, Malhuer, and Baker counties.
Community grants are designed to create and sustain breast health programs in two categories: Saving lives through education and outreach or Breast Cancer Support programs that assist people during treatment and survivorship. These grants are funded up to $35,000 per year. For more details, see the Community Grants page.
This program is now a service-area wide program serving all of Oregon and Clark, Skamania and Cowlitz counties in SW Washington in partnership with the American Cancer Society. Please see our Transportation Program page for more details.
Screening and Treatment:
The local Affiliate partners with the States of Oregon and Washington to provide screening services to low income, uninsured women throughout the service area. Eligible women who are diagnosed through the state screening programs, are enrolled in Medicaid services to provide treatment for breast cancer.